Back to Search
JULIE MARIS, PHARMD
PHARMD
Pharmacist
NPI: 1508193004Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
PMID 19435921·Cancer Res·2009
8-other
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
PMID 19412175·Nat Genet·2009
8-other
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
PMID 19554570·Pediatr Blood Cancer·2009
7-preclinical
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
PMID 19530234·Pediatr Blood Cancer·2009
8-other
Initial testing of aplidin by the pediatric pre-clinical testing program.
PMID 19418543·Pediatr Blood Cancer·2009
7-preclinical
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
PMID 19401703·Br J Cancer·2009
8-other
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
PMID 19171714·J Clin Oncol·2009
3-trial
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program.
PMID 19418547·Pediatr Blood Cancer·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1902 RICHMOND RD
TEXARKANA, TX 75503 - Phone
- (903) 838-3988
Quick Facts
- NPI
- 1508193004
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile